Chest
The most recent articles from:
Chest
2022
-
Observational Study
Inhaled nitric oxide versus epoprostenol during acute respiratory failure: an observational target trial emulation.
The inhaled vasodilators nitric oxide and epoprostenol may be initiated to improve oxygenation in mechanically ventilated patients with severe acute respiratory failure (ARF); however, practice patterns and head-to-head comparisons of effectiveness are unclear. ⋯ Large variation exists in the use of initial inhaled vasodilator for respiratory failure across US hospitals. Comparative effectiveness analyses identified no differences in outcomes based on inhaled vasodilator type.